Skip to main content
. 2026 Feb 3;18(2):e102911. doi: 10.7759/cureus.102911

Table 6. Summary of visual acuity outcomes across corneal collagen cross-linking protocols in progressive keratoconus.

A-CXL: accelerated corneal cross-linking; BCVA: best corrected visual acuity; CDVA: corrected distance visual acuity; CXL: corneal collagen cross-linking; logMAR: logarithm of the minimum angle of resolution; NR: not reported; NS: not significant (p-value > 0.05); P: p-value; TE-CXL: transepithelial corneal cross-linking; UDVA: uncorrected distance visual acuity

Study Protocol UDVA Change CDVA/BCVA Change Timepoint
Wittig-Silva et al., 2014 [36] Dresden -0.15 ± 0.06 logMAR (p < 0.01) -0.09 ± 0.03 logMAR ( p < 0.01) 3 years
Strmeňová et al., 2015 [34] Dresden NR -0.048 logMAR (p < 0.01) 2 years
Bikbova et al., 2016 [40] I-CXL NS -0.07 logMAR (p < 0.05) 2 years
Bikbova et al., 2016 [40] Dresden NS -0.02 logMAR (p < 0.05) 2 years
Choi et al., 2017 [16] Dresden -0.09 ± 0.09 (p < 0.01) NR 6 months
Choi et al., 2017 [16] A-CXL NS NR 6 months
Stulting et al., 2018 [59] TE-CXL -0.146 logMAR (p < 0.0001) -0.108 logMAR (p < 0.0001) 2 years
Kobashi et al., 2020 [12] Dresden NS -0.02 logMAR (p < 0.0001) 1 year
Kobashi et al., 2020 [12] A-CXL NS NS 1 year
Ferdi et al. (Registry), 2023 [2] Dresden -0.074 logMAR (p < 0.001) NR 1 year
Ferdi et al. (Registry), 2023 [2] Dresden -0.138 logMAR (p < 0.001) NR 5 years
Kandel et al. (Registry), 2024 [24] Dresden -0.204 logMAR (95% CI: -0.158 to -0.25) -0.114 logMAR (95% CI: -0.07 to -0.156) 5 years
Kandel et al. (Registry), 2024 [24] A-CXL -0.098 logMAR (95% CI: -0.032 to -0.164) -0.004 logMAR (95% CI: -0.044 to +0.05) 5 years